Screener
Royalty Pharma RPRX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Royalty Pharma in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Financial royalty assets | 889,454 | 854,386 |
| Available for sale debt securities | 25,000 | 18,800 |
| Other royalty income receivable | 31,474 | 29,316 |
| Other current assets | 6,656 | 6,893 |
| Total current assets | 1,764,570 | 1,528,091 |
| Financial royalty assets, net | 16,192,717 | 16,208,482 |
| Equity securities | 241,918 | 171,312 |
| Available for sale debt securities | 372,100 | 419,000 |
Item 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Royalty Pharma's prepaid & other current?
- Royalty Pharma (RPRX) reported prepaid & other current of $6.66M in Q2 2026.
- How has Royalty Pharma's prepaid & other current changed year-over-year?
- Royalty Pharma's prepaid & other current increased by 49.5% year-over-year, from $4.45M to $6.66M.
- What is the long-term trend for Royalty Pharma's prepaid & other current?
- Over 5 years (2020 to 2025), Royalty Pharma's prepaid & other current has grown at a -4.3% compound annual growth rate (CAGR), from $8.6M to $6.89M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Royalty Pharma's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude